The Valley Desk

NCT02477748 · Interventional trial

The MEASURE Study - A Phase 3 Study of MDX 1400 mg Daily Compared With Placebo in Adults With ADHD

Overall registry status Terminated

Phase 3

Conditions Attention Deficit Hyperactivity Disorder (ADHD)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov